While Bruton’s tyrosine kinase inhibitors are often hailed as the next big breakthrough in multiple sclerosis, Immunic Therapeutics and others are leveraging neuroprotective targets and remyelination ...

Treatment with Sanofi's frexalimab was seen in a study to safely maintain disease control over 2.5 years in adults with ...

Discover the groundbreaking medical trial offering new hope for autoimmune diseases and the first courageous patient behind ...

The CAR T-cell therapy equecabtagene autoleucel, or eque-cel, was shown in trial to improve walking ability for five ...

A multicenter phase 3 trial comparing ocrelizumab to fingolimod for children with MS achieved its noninferiority primary ...

Ryan Haumschild, PharmD, MS, MBA: One of the things I see is, pharmacists play an important role in treatment recommendations and follow-up as well. A lot of times when you’re counseling a patient or ...

Share on Pinterest A recent study reports that starting treatment at the first signs of MS symptoms could help slow disease progression. Jennifer Blount/Getty Images A recent study finds getting ...

Radiologically isolated syndrome (RIS) is a condition in which a person’s MRI brain scan shows abnormalities and lesions like those seen in multiple sclerosis (MS), but they haven’t experienced any MS ...

OMAHA, Neb. (WOWT/Gray News) - A Nebraska woman has become the first patient in the world to undergo a groundbreaking new treatment for multiple sclerosis. Seven years ago, Jan Janisch-Hanzlik began ...

Initiating treatment for multiple sclerosis (MS) within 6 months of the first symptoms is associated with a significantly lower risk for severe disability one decade later, a new study suggests.

Thomas Leist, MD and Darin Okuda, MD provide insight into first-line treatment selection for MS and the patient factors involved. Maria Lopes, MD, MS discusses payer considerations and challenges in ...

Illustration showing demylination, a process in which the myelin sheath of neurons is damaged. This damage is seen in demyelinating diseases, such as multiple sclerosis and other demyelinating ...